Hallway Conversations is a series of audio podcasts with thought leaders and newsmakers in the field of epilepsy on a range of seizure related topics. The series covers a range of topics and are intended to address a wide range of audiences.

We hope that you find the series informative and helpful and that you join us in listening on a regular basis.

 Dr. Joseph Sirven, Editor-in-Chief

Saliva Testing for AEDs

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Oren S. Knopfmacher, PhD, CEO & Co-founder of Avails Medical, Inc. They will be talking about Saliva Testing for AEDs. Dr. Knopfmacher won the $75,000 Judge's Choice Award during the Shark Tank Competition at the Epilepsy Pipeline Conference 2014.

An Algorithm on the Treatment of Epilepsy in Patients with a Normal MRI

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Lara Jehi, MD from the Cleveland Clinic Epilepsy Center. They will be discussing an algorithm on the treatment of epilepsy in patients with a normal MRI. This was also the subject of a 2013 AES Annual Course.

An Algorithm for Diagnosis of Nonlesional Epilepsy

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Jorge G. Burneo, MD, MSPH, Associate Professor of Neurology, Epidemiology, and Biostatistics, and Director of the EEG Laboratory and Co-Director, Epilepsy Programme at the University of Western Ontario's London Health Sciences Centre. They will be discussing an algorithm for the diagnosis of nonlesional epilepsy.

Summer Camps and Epilepsy

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Patricia Dean, ARNP, MSN, from the Brain Institute at Miami Childrens Hospital, and Sandra Cushner Weinstein, PT, LICSW, LCSW-C, Director of Services and Camps, Department of Neurology, at George Washington University School of Medicine. With summer rapidly approaching, they will be talking about Epilepsy Camps. After the interview, you can find out more on the Brainy Camps webpage (www.brainycamps.com) and on the epilepsy.com summer camp section (www.epilepsy.com/get-help/managing-your-epilepsy/summer-camp).

SAGE Trial for Refractory Status Epilepticus

In this episode of Epilepsy.com's Hallway Conversations, Dr. Joseph Sirven, Professor of Neurology at Mayo Clinic Arizona and Editor-in-Chief of Epilepsy.com, interviews Steve Kanes, MD, PhD, Chief Medical Officer at SAGE Therapeutics about the SAGE 547 Trial in Status Epilepticus. SAGE-547 is currently being evaluated in a Phase 1/2 clinical trial for super-refractory status epilepticus (SRSE). SAGE-547 demonstrated robust findings in preclinical models of SE, including significantly increased efficacy over current standard-of-care benzodiazepine treatment, and compelling early human experience data. After the interview, you can learn more about refractory epilepsy at: http://www.epilepsy.com/learn/refractory-epilepsy.

Pages